Eventide Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Eventide Asset Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-246,700	Closed	-$1.3M	–	137
2016 Q1	$1.3M	Hold	246,700	–	–	0.07%	108
2015 Q4	$1.94M	Buy	246,700 +49,600	+25%	+$427K	0.1%	102
2015 Q3	$1.67M	Buy	197,100 +84,500	+75%	+$779K	0.1%	103
2015 Q2	$1.23M	Hold	112,600	–	–	0.07%	104
2015 Q1	$1.57M	Buy	112,600 +12,600	+13%	+$193K	0.12%	100
2014 Q4	$1.69M	Buy	+100,000	New	+$1.46M	0.18%	85

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eventide Asset Management's INFI Position: Q2 2016 in Review

Eventide Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 246,700 shares — an estimated $1.3M sold.

Eventide Asset Management first reported a position in INFI in Q4 2014 and held it in 6 quarters. The position peaked at $1.94M in Q4 2015. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

Eventide Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Eventide Asset Management sold 246,700 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $1.3M.
Eventide Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 6 quarters.
Eventide Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $1.94M in Q4 2015.
107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on Eventide Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.